Axim Biotechnologies (OP: AXIM )

0.5799 USD -0.0501 (-7.95%)

Official Closing Price Updated: 3:59 PM EST, Mar 5, 2021 Add to My Watchlist

Price and Volume

Volume	175,800
Open	0.6240
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.6300
Today's Range	0.5100 - 0.6760
52wk Range	0.1000 - 1.440
Shares Outstanding	56,736,450
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients

February 03, 2021

AXIM® Biotechnologies Releases Preprint Manuscript Describing the Development of Company’s Rapid Point-of-Care Test That Measures COVID-19 Neutralizing Antibodies

January 11, 2021

Performance

YTD	+39.73%	+39.73%
1 Month	-0.70%	-0.70%
3 Month	+38.07%	+38.07%
6 Month	-6.47%	-6.47%
1 Year	+146.87%	+146.87%

More News

AXIM® Biotechnologies Completes Successful Covid-19 Live Virus Test and Files Amended EUA for Portable 10 Minute Rapid Diagnostic Test for Neutralizing Antibodies

December 15, 2020

AXIM® Biotechnologies to Present at the 13th Annual LD Micro Main Event Investor Conference on Monday, December 14

December 14, 2020

AXIM® Biotechnologies Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for Patent; Company’s Fourth COVID-19 Test-Focused Patent Application

December 03, 2020

AXIM® Biotechnologies Applauds Vaccine Producers, Highlights Need for Rapid Antibody Testing to Ensure Immunity

November 10, 2020

AXIM® Biotechnologies Issues Update Letter to Shareholders

October 28, 2020

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for World’s First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)

October 06, 2020

Medical Marijuana, Inc. Investment Company AXIM Biotechnologies Files Patent for Worlds First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)

October 06, 2020

AXIM® Biotechnologies Files Patent for Virus Binding Recombinant Protein for SARS-CoV-2 (COVID-19) and Begins Manufacturing

September 30, 2020

AXIM® Biotechnologies Files Patent for World’s First Face Mask Designed to Capture SARS-CoV-2 COVID-19

September 29, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.